Open AccessRisk Of Pulmonary Artery Thrombosis In Type 2 DM Patients Hospitalized With Covid-19
Author(s) -
Nodirbek Ilkhomjon Ogli Yakubov,
Dilfuzahon Mamarasulova,
N. Dadamyants,
Anvar Arabbayevich Dalimov
Publication year - 2021
Publication title -
the american journal of medical sciences and pharmaceutical research
Language(s) - English
Resource type - Journals
ISSN - 2689-1026
DOI - 10.37547/tajmspr/volume03issue08-07
Subject(s) - medicine , cardiology , thrombosis , thrombus , type 2 diabetes , proinflammatory cytokine , ferritin , venous thrombosis , body mass index , diabetes mellitus , covid-19 , disease , inflammation , endocrinology , infectious disease (medical specialty)
For the first time on the Fergana Valley model, prognostic markers of the risk of thrombotic complications in COVID-19 patients with type 2 diabetes were studied. It was found that the level of glycemia, the concentration of proinflammatory cytokines IL-6, ferritin and CRP, and the marker of thrombus formation - d dimer, have a prognostic significance, with the maximum prognostic significance of the concentration of CRP. The prognostic significance of ultrasound in the aspect of thrombosis of the branches of the PA in patients with COVID-19 against the background of type 2 diabetes was established. Predictor markers are mean PA pressure, LV myocardial mass index, signs of increased intraventricular pressure in the RV, and evidence of peripheral venous thrombosis.